Metadata standards to support deployment of Digital Health Technologies in Clinical Trials in Parkinson’s Disease – Derek Hill, et al. Abstract # 1289
Identifying and Controlling Variability in Digital Health Measures in Parkinson’s Disease Clinical Trials – George Roussos, et al. Abstract # 342
Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium – Martijn Müller, et al. Abstract # 341
The Development of a Parkinson’s Disease Biomarker Inventory Dashboard – Michael Pauley, et al. Abstract # 308
Model Innovation in Parkinson’s Disease Drug Development: Linking Quantitative Systems Pharmacology to the Patient Voice – Jeff Barrett, et al. Abstract # 287
Considerations for Participation in PPP Projects: Learnings from the Critical Path for Parkinson’s Consortium, D. Stephenson Session: # S0802-L, Understanding of Different Set Ups of PPP, Benefits of PPPs and Learnings of Recent Projects to Facilitate
C-Path Program and Consortia Leaders Selected to Serve in Sr. Vice President and Vice President Roles Inish O’Doherty and Sudhir Sivakumaran will lead new programs; Stephen Joel Coons and John-Michael Sauer move into Sr. VP roles.
C-Path Receives FDA Qualification for the Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) TUCSON, Ariz., March 9, 2021 — Critical Path Institute’s (C-Path) Patient-Reported Outcome (PRO) Consortium announces the
March 8, 2021 CORRECTION: Evaluation of Multiple Sclerosis Disability Outcome Measures Using Pooled Clinical Trial Data
March 31, 2021 View Now: 2021 PSTC Virtual Workshop—March 31, 2021 The Predictive Safety Testing Consortium (PSTC) launched its 15th anniversary celebration with a virtual public workshop. Scientis